Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Sensory network dysfunction, behavioral impairments, and their reversibility in an Alzheimer's β-amyloidosis mouse model.

Wesson DW, Borkowski AH, Landreth GE, Nixon RA, Levy E, Wilson DA.

J Neurosci. 2011 Nov 2;31(44):15962-71. doi: 10.1523/JNEUROSCI.2085-11.2011.

2.

Olfactory dysfunction correlates with amyloid-beta burden in an Alzheimer's disease mouse model.

Wesson DW, Levy E, Nixon RA, Wilson DA.

J Neurosci. 2010 Jan 13;30(2):505-14. doi: 10.1523/JNEUROSCI.4622-09.2010.

3.

Chronic anti-murine Aβ immunization preserves odor guided behaviors in an Alzheimer's β-amyloidosis model.

Wesson DW, Morales-Corraliza J, Mazzella MJ, Wilson DA, Mathews PM.

Behav Brain Res. 2013 Jan 15;237:96-102. doi: 10.1016/j.bbr.2012.09.019. Epub 2012 Sep 20.

4.

Spared piriform cortical single-unit odor processing and odor discrimination in the Tg2576 mouse model of Alzheimer's disease.

Xu W, Lopez-Guzman M, Schoen C, Fitzgerald S, Lauer SL, Nixon RA, Levy E, Wilson DA.

PLoS One. 2014 Sep 2;9(9):e106431. doi: 10.1371/journal.pone.0106431. eCollection 2014.

5.

Early hyperactivity in lateral entorhinal cortex is associated with elevated levels of AβPP metabolites in the Tg2576 mouse model of Alzheimer's disease.

Xu W, Fitzgerald S, Nixon RA, Levy E, Wilson DA.

Exp Neurol. 2015 Feb;264:82-91. doi: 10.1016/j.expneurol.2014.12.008. Epub 2014 Dec 12.

6.

Immunization targeting a minor plaque constituent clears β-amyloid and rescues behavioral deficits in an Alzheimer's disease mouse model.

Morales-Corraliza J, Schmidt SD, Mazzella MJ, Berger JD, Wilson DA, Wesson DW, Jucker M, Levy E, Nixon RA, Mathews PM.

Neurobiol Aging. 2013 Jan;34(1):137-45. doi: 10.1016/j.neurobiolaging.2012.04.007. Epub 2012 May 18.

7.

Amyloid beta inhibits olfactory bulb activity and the ability to smell.

Alvarado-Martínez R, Salgado-Puga K, Peña-Ortega F.

PLoS One. 2013 Sep 26;8(9):e75745. doi: 10.1371/journal.pone.0075745. eCollection 2013.

8.

Interneurons and beta-amyloid in the olfactory bulb, anterior olfactory nucleus and olfactory tubercle in APPxPS1 transgenic mice model of Alzheimer's disease.

Saiz-Sanchez D, De La Rosa-Prieto C, Ubeda-Bañon I, Martinez-Marcos A.

Anat Rec (Hoboken). 2013 Sep;296(9):1413-23. doi: 10.1002/ar.22750. Epub 2013 Jul 31.

9.

Coenzyme Q10 decreases amyloid pathology and improves behavior in a transgenic mouse model of Alzheimer's disease.

Dumont M, Kipiani K, Yu F, Wille E, Katz M, Calingasan NY, Gouras GK, Lin MT, Beal MF.

J Alzheimers Dis. 2011;27(1):211-23. doi: 10.3233/JAD-2011-110209.

10.

Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease.

Ho L, Qin W, Pompl PN, Xiang Z, Wang J, Zhao Z, Peng Y, Cambareri G, Rocher A, Mobbs CV, Hof PR, Pasinetti GM.

FASEB J. 2004 May;18(7):902-4. Epub 2004 Mar 19.

11.

An increase in Abeta42 in the prefrontal cortex is associated with a reversal-learning impairment in Alzheimer's disease model Tg2576 APPsw mice.

Zhuo JM, Prakasam A, Murray ME, Zhang HY, Baxter MG, Sambamurti K, Nicolle MM.

Curr Alzheimer Res. 2008 Aug;5(4):385-91.

PMID:
18690835
12.

Amyloid-β deposition and olfactory dysfunction in an Alzheimer's disease model.

Wu N, Rao X, Gao Y, Wang J, Xu F.

J Alzheimers Dis. 2013;37(4):699-712. doi: 10.3233/JAD-122443.

PMID:
23948910
13.

Differential expression of interneuron populations and correlation with amyloid-β deposition in the olfactory cortex of an AβPP/PS1 transgenic mouse model of Alzheimer's disease.

Saiz-Sanchez D, Ubeda-Bañon I, De la Rosa-Prieto C, Martinez-Marcos A.

J Alzheimers Dis. 2012;31(1):113-29. doi: 10.3233/JAD-2012-111889.

PMID:
22543847
14.

Repetitive mild brain trauma accelerates Abeta deposition, lipid peroxidation, and cognitive impairment in a transgenic mouse model of Alzheimer amyloidosis.

Uryu K, Laurer H, McIntosh T, Praticò D, Martinez D, Leight S, Lee VM, Trojanowski JQ.

J Neurosci. 2002 Jan 15;22(2):446-54.

15.

Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.

Dragicevic N, Mamcarz M, Zhu Y, Buzzeo R, Tan J, Arendash GW, Bradshaw PC.

J Alzheimers Dis. 2010;20 Suppl 2:S535-50. doi: 10.3233/JAD-2010-100342.

PMID:
20463404
16.
17.

Transient enriched housing before amyloidosis onset sustains cognitive improvement in Tg2576 mice.

Verret L, Krezymon A, Halley H, Trouche S, Zerwas M, Lazouret M, Lassalle JM, Rampon C.

Neurobiol Aging. 2013 Jan;34(1):211-25. doi: 10.1016/j.neurobiolaging.2012.05.013. Epub 2012 Jun 21.

PMID:
22727275
18.

Loss of LR11/SORLA enhances early pathology in a mouse model of amyloidosis: evidence for a proximal role in Alzheimer's disease.

Dodson SE, Andersen OM, Karmali V, Fritz JJ, Cheng D, Peng J, Levey AI, Willnow TE, Lah JJ.

J Neurosci. 2008 Nov 26;28(48):12877-86. doi: 10.1523/JNEUROSCI.4582-08.2008.

19.

Corticotrophin releasing factor accelerates neuropathology and cognitive decline in a mouse model of Alzheimer's disease.

Dong H, Murphy KM, Meng L, Montalvo-Ortiz J, Zeng Z, Kolber BJ, Zhang S, Muglia LJ, Csernansky JG.

J Alzheimers Dis. 2012;28(3):579-92. doi: 10.3233/JAD-2011-111328.

20.

Inflammation and cerebral amyloidosis are disconnected in an animal model of Alzheimer's disease.

Quinn J, Montine T, Morrow J, Woodward WR, Kulhanek D, Eckenstein F.

J Neuroimmunol. 2003 Apr;137(1-2):32-41.

PMID:
12667645
Items per page

Supplemental Content

Write to the Help Desk